Search results
Vigil Neuroscience (NASDAQ:VIGL) versus BioAtla (NASDAQ:BCAB) Head-To-Head Comparison
ETF DAILY NEWS· 4 hours agoBioAtla (NASDAQ:BCAB – Get Free Report) and Vigil Neuroscience (NASDAQ:VIGL – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two ...
...-Phase Retina Pipeline including Advancements with High Drug-Antibody-Ratio Therapeutics Built on...
Casper Star-Tribune· 3 days agoKodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases ...
Chinese companies lead ADC pipeline
Pharmaceutical Technology via Yahoo Finance· 4 days agoAntibody drug conjugates (ADCs) are a rapidly growing therapeutic class that leading data and analytics company GlobalData forecasts will generate more...
Nanotubes, nanoparticles and antibodies detect tiny amounts of fentanyl
Phys.org· 3 days agoFentanyl is a synthetic opioid and one of the main drivers in overdose deaths in the United States,...
Spyre Therapeutics Announces Grants of Inducement Awards
The Pilot News· 1 day agoSpyre Therapeutics, Inc. (NASDAQ: SYRE) (the "Company" or "Spyre"), a development-stage biotechnology company advancing best-in-class antibody engineering, rational therapeutic ...
Drug appears to reverse type 1 diabetes in mice
Futurity· 5 days agoAn experimental monoclonal antibody drug appears to prevent and reverse the onset of clinical type 1 diabetes in mice, and in some cases, to lengthen the animals’ lifespan ...
...Drug (IND) Application for EB-105 - A Novel Trispecific Fusion Antibody for Diabetic Macular...
WTNH-TV New Haven· 5 days agoEB-105 is a novel trispecific fusion antibody targeting VEGF-A (and isomers), VEGF-B, placental...
Patients with rheumatoid arthritis have unique and complex autoantibody patterns, study reveals
Medical Xpress· 4 days agoRheumatoid arthritis is a chronic autoimmune disease that primarily affects the joints, causing...
Regeneron Pharmaceuticals Inc (REGN) Q1 2024 Earnings Call Transcript Highlights: Key Financial ...
GuruFocus.com via Yahoo Finance· 2 days agoRevenue: Grew 7% year-over-year to $3.1 billion, excluding COVID antibodies contributions. Net Income: First quarter diluted net income per share was $9.55. Free Cash Flow: Generated $1.4 billion ...
Nanotubes, nanoparticles, and antibodies detect tiny amounts of fentanyl
Newswise· 3 days agoA research team at Pitt led by Alexander Star, a chemistry professor in the Kenneth P. Dietrich...
